|
|||||
|
|
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) |
|
| Authors: | Dan P Zandberg Sandra Rollins Olga Goloubeva Robert E Morales Ming Tan Rodney Taylor Jeffrey S Wolf Lisa M Schumaker Kevin J Cullen Ann Zimrin Robert Ord Joshua E Lubek Mohan Suntharalingam John C Papadimitriou Dean Mann Scott E Strome Martin J Edelman |
| Institution: | 1. University of Maryland Marlene and Stewart Greenebaum Cancer Center, 22 South Greene St. Rm N9E29, Baltimore, MD, 21201, USA 2. Division of Medical Oncology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA 3. Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA 4. Department of Radiology, University of Maryland School of Medicine, Baltimore, MD, USA 5. Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown Lombardi Comprehensive Cancer Center, washington, DC, USA 6. Department of Otorhinolaryngology-Head and Neck Surgery, University of Maryland, Baltimore, MD, USA 7. Department of Oral and Maxillofacial Surgery, University of Maryland School of Medicine, Baltimore, MD, USA 8. Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |